EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Protein‐extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation

Johanna Ranta-Aho iD, Kevin J Felice, Per Harald Jonson iD, Jaakko Sarparanta, Cédric Yvorel, Ines Harzallah, Renaud Touraine, Lynn Pais, Christina A Austin-Tse, Vijay S Ganesh, Melanie C O'Leary, Heidi L Rehm and 5 more

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52154 ↗

At a glance

Journal article in Annals of Clinical and Translational Neurology, 2024. Written by Johanna Ranta-Aho and 16 co-authors. Institution: Folkhälsan Research Center, Haartmaninkatu 8, 00290, Helsinki, Finland. Major MEDLINE topics: Actinin, Frameshift Mutation, Phenotype. Cited 2 times so far (Crossref); 41 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Chan Zuckerberg Initiative, NHGRI NIH HHS, Sigrid Jusélius Foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

The objective of the study is to characterize the pathomechanisms underlying actininopathies. Distal myopathies are a group of rare, inherited muscular disorders characterized by progressive loss of muscle fibers that begin in the distal parts of arms and legs. Recently, variants in a new disease gene, ACTN2 , have been shown to cause distal myopathy. ACTN2 , a gene previously only associated with cardiomyopathies, encodes alpha‐actinin‐2, a protein expressed in both cardiac and skeletal sarcomeres. The primary function of alpha‐actinin‐2 is to link actin and titin to the sarcomere Z‐disk. New ACTN2 variants are continuously discovered; however, the clinical significance of many variants remains unknown. Thus, lack of clear genotype–phenotype correlations in ACTN2 ‐related diseases, actininopathies, persists.

Methods

Functional characterization in C2C12 cell model of several ACTN2 variants is conducted, including frameshift and missense variants associated with dominant and recessive actininopathies. We assess the genotype–phenotype correlations of actininopathies using clinical data from several patients carrying these variants.

Results

The results show that the missense variants associated with a recessive form of actininopathy do not cause detectable alpha‐actinin‐2 aggregates in the cell model. Conversely, dominant frameshift variants causing a protein extension do form alpha‐actinin‐2 aggregates.

Interpretation

The results suggest that alpha‐actinin‐2 aggregation is the disease mechanism underlying some dominant actininopathies, and thus, we recommend that protein‐extending frameshift variants in ACTN2 should be classified as pathogenic. However, this mechanism is likely elicited by only a limited number of variants. Alternative functional characterization methods should be explored to further investigate other molecular mechanisms underlying actininopathies.

Subjects

MeSH terms (MEDLINE)

ActininFrameshift MutationPhenotypeHumansMaleDistal MyopathiesFemaleProtein Aggregation, PathologicalAnimalsMiceGenetic Association StudiesAdultMutation, Missense

Substances

ActininACTN2 protein, human

Authors and institutions

  • Folkhälsan Research Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
  • Department of Medical Genetics, Medicum, University of Helsinki, Haartmaninkatu 8, Helsinki, 00290, Finland.
  • Department of Neuromuscular Medicine, Hospital for Special Care, 2150 Corbin Avenue, New Britain, Connecticut, 06053, USA.
  • Cardiology Department, Hôpital Nord, Hôpital Nord, CHU de Saint Etienne, Avenue Albert Raimond, Saint Priest-en-Jarez, 42270, France.
  • Genetic Department, Hôpital Nord, CHU de Saint Etienne, Avenue Albert Raimond, Saint Priest-en-Jarez, 42270, France.
  • Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 105 Broadway, Cambridge, Massachusetts, 02142, USA.

ORCID profiles: Johanna Ranta-Aho, Per Harald Jonson, Sub Subramony, Marco Savarese

Funding

  • Chan Zuckerberg Initiative
  • NHGRI NIH HHS
  • Sigrid Jusélius Foundation
  • NEI NIH HHS
  • Folkhälsan Research Foundation
  • Research Council of Finland
  • Jane and Aatos Erkko Foundation
  • Emil Aaltonen Foundation

Cite

APA

Ranta-Aho, J., Felice, K. J., Jonson, P. H., Sarparanta, J., Yvorel, C., Harzallah, I., Touraine, R., Pais, L., Austin-Tse, C. A., Ganesh, V. S., O'Leary, M. C., Rehm, H. L., Hehir, M. K., Subramony, S., Wu, Q., Udd, B., & Savarese, M. (2024). Protein‐extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52154

Vancouver

Ranta-Aho J, Felice KJ, Jonson PH, Sarparanta J, Yvorel C, Harzallah I, et al. Protein‐extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52154

BibTeX
@article{RantaAho2024,
  author = {Ranta-Aho, Johanna and Felice, Kevin J and Jonson, Per Harald and Sarparanta, Jaakko and Yvorel, Cédric and Harzallah, Ines and Touraine, Renaud and Pais, Lynn and Austin-Tse, Christina A and Ganesh, Vijay S and O'Leary, Melanie C and Rehm, Heidi L and Hehir, Michael K and Subramony, Sub and Wu, Qian and Udd, Bjarne and Savarese, Marco},
  title = {Protein‐extending ACTN2 frameshift variants cause variable myopathy phenotypes by protein aggregation},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52154}
}
Start for free →